Newsfeeds - Spark Newswire

1 minute read

Here’s Why Ginkgo Bioworks Shares Are Rising

Today, 10:35 AM

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 22.0% at $4.56 after the company reported better-than-expected fourth-quarter sales results and issued FY22 sales guidance above analyst estimates.

DNA

1 minute read

Ginkgo Bioworks Holdings Q4 Adj. EBITDA $1M vs Loss $51M In Same Qtr. Last Year, GAAP Loss From Operations $1.7B, Sales $148.00M Beat $94.81M Estimate

By Benzinga Newsdesk

Today, 10:35 AM

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly sales of $148.00 million which beat the analyst consensus estimate of $94.81 million by 56.10 percent. This is a 362.50 percent increase over sales of $32.00

DNA

3 minute read

Earnings Scheduled For March 28, 2022

By Benzinga Insights

Today, 10:35 AM

Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.

ABOS

27 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 10:35 AM

During Tuesday's session, 454 stocks hit new 52-week lows.

ADAG

2 minute read

Ginkgo Bioworks Signs Definitive Agreement To Acquire FGen AG; Size Of Acquisition Not Disclosed

By Bill Haddad

Today, 10:35 AM

Ginkgo Bioworks (NYSE:DNA), the leading horizontal platform for cell programming, today announced the entry into a definitive agreement to acquire FGen AG ("FGen"), a Swiss company specializing in strain

DNA

2 minute read

23 Stocks That Have Sold Off Hard Since The Russia-Ukraine War Began

By AJ Fabino

Today, 10:35 AM

The S&P 500 is having a rough start to 2022, down 11.27% year to date. Since Russia invaded Ukraine on Feb. 24, the S&P 500 has fallen an additional 0.78%. Following are lists of sectors via Fidelity that have done well or poorly, as well as 23 of the most sold-off stocks since the war began. The worst performing sectors over the last month are:

ARNC